Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs150178133 | chr8:103163756 | T/TGCC | 0.000169 | 128 | 42.18 | 41.2 | 24.43 | KM Plot |
| TGCT | rs1546252 | chr5:1796520 | C/T | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs1546253 | chr5:1796564 | C/T | 4.04E-7 | 133 | 42.27 | 45.83 | 20.6 | KM Plot |
| TGCT | rs1549071 | chr14:78172449 | C/T | 4.42E-9 | 128 | 45.47 | 37.5 | 9.32 | KM Plot |
| TGCT | rs1554090 | chr16:27807751 | C/T | 1.04E-5 | 133 | 46.53 | 33.55 | 17.27 | KM Plot |
| TGCT | rs1555046 | chr6:28329037 | C/G | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs1555047 | chr6:28328683 | C/T | 0 | 134 | 45.83 | 29.65 | 0.57 | KM Plot |
| TGCT | rs1568588 | chr3:172465874 | G/A | 9.33E-5 | 132 | 25.8 | 37.42 | 42.27 | KM Plot |
| TGCT | rs16853856 | chr1:14576548 | C/G | 8.86E-7 | 133 | 42.27 | 28.8 | 0.57 | KM Plot |
| TGCT | rs16864244 | chr2:177559166 | A/T | 0 | 128 | 45.93 | 36.63 | 0.57 | KM Plot |
| TGCT | rs16864246 | chr2:177559549 | G/A | 0 | 128 | 45.93 | 36.63 | 0.57 | KM Plot |
| TGCT | rs16869009 | chr8:103084695 | C/T | 0.000111 | 134 | 42.1 | 36.1 | 48.45 | KM Plot |
| TGCT | rs16872670 | chr5:74929312 | G/A | 8.14E-5 | 133 | 46.07 | 25.77 | 5.33 | KM Plot |
| TGCT | rs16887886 | chr8:116910767 | T/C | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs16899748 | chr8:125585547 | G/A | 1.92E-5 | 132 | 41.97 | 46.77 | 22.68 | KM Plot |